Sermorelin vs CJC-1295: GHRH-Analog Research Compared

### Shared biology Sermorelin and CJC-1295 (with or without DAC) are **growth hormone–releasing hormone (GHRH) analogs**. They amplify the pituitary’s endogenous GH pulse rather than acting as ghrelin-mimetic secretagogues (GHRP class). ### Practical research differences - **Sermorelin**: shorter GHRH fragment historically used in research and clinical development contexts; kinetics differ from long-acting analogs. - **CJC-1295 (no DAC)**: engineered for **extended plasma exposure** vs native GHRH(1-44); often discussed alongside GHRP co-administration in research forums—but protocols are not provided here. ### Synergy note Our article on /blog/cjc-1295-ipamorelin-mechanism covers pairing GHRH-class tools with selective secretagogues. ### RUO Laboratory research only. *Both sermorelin and CJC-1295 variants are available from peptide limited for qualified research use.*